Search results

Selected filters:

Litigation
Europe

Article type

Topic

Sector

Jurisdictions

444 results found for your search

Sort options
10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

05 July 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’

03 July 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market

27 June 2019

Huawei has reaped $1.4 billion in licence fees since 2015, white paper says

The Chinese company also revealed its royalty outflow – $6 billion since it took its first licence in 2001, 80% of which has gone to US companies

26 June 2019

Despite UK High Court setback for Pfizer, Arrow declarations remain a valuable litigation tool

The latest judgment is one of only a few to provide an indication of when the courts will grant the pre-emptive litigation defence remedy, which was issued for the first time in 2017

17 June 2019

Why it's time for the world of patents to embrace diversity and gender equality

Special IAM boardroom session at IPBC Global 2019 focuses on how to get more women involved in senior positions in the global IP market - and why everyone will win when it happens

13 June 2019

Huawei’s $1 billion Verizon demand: politics or profit?

Ongoing royalty negotiations are revealed after US network operator reportedly notifies government. Why the conflict, which follows a 2016 dispute with T-Mobile, may alarm Nokia and Ericsson

12 June 2019

Group including Ericsson Nokia, InterDigital and Qualcomm releases SEP licence negotiation principles

Move designed to influence debate in Europe and comes on same day as implementers publish their own guidelines.  

11 June 2019

Taiwan Semiconductor spins patents to gene sequencing leader

Transfer of microfluidics tech comes as San Diego-based Illumina faces a fierce IP fight with an upstart Chinese rival

06 June 2019

Siemens asserting Chinese wireless patents against four local mobile firms

Following successful invalidation petitions lodged by Vivo against the German company, industry sources tell IAM that Oppo, Xiaomi and Meizu also face SEP assertions in specialised IP courts

04 June 2019

The SEP state of play in Europe’s major jurisdictions

Recent decisions in Germany, the UK, the Netherlands and France have shed much greater light on where the continent’s top patent litigation venues are heading on FRAND-related disputes

31 May 2019

Growing SEP FRAND case law is adding clarity, insists Ericsson assertion chief

Opinion from East Texas judge adds to earlier win for Swedish telco in lawsuit against HTC, but looming appeals give rights owners plenty to think about

30 May 2019

AB InBev IP exec explains how he is helping to shift attitudes one six-pack at a time

With the giant brewer facing off against Heineken in court, Michael Swita sets out how innovation and patents are becoming a far bigger consideration in the industry

28 May 2019

US biotech aims to curb China’s genomics leader with pair of European lawsuits

Shenzhen BGI was once the biggest purchaser of Illumina’s gene sequencing machines. Now the two are on opposite sides of an expanding patent battle

24 May 2019

Plausibility after pregabalin – how much information must a patent disclose?

Having been the subject of a key decision from the UK Supreme Court, plausibility has been an increasingly important topic for life sciences rights holders to consider in both patent prosecution and litigation.